1 Introduction Diabetes, a significant global health challenge, is anticipated to reach $1.054 trillion in healthcare costs by 2045, with Type 2 Diabetes Mellitus (T2DM) affecting an estimated 783 million individuals ( Numerous studies have investigated the relationship between DPP-4 inhibitors and the risk of biliary diseases
+ How should I reconstitute and store this compound
On August 28, 2024, Eli Lilly and Company submitted a nomination to request that its GLP-1 product, tirzepatide, be added to FDAs Demonstrable Difficulties for Compounding (DDC) lists
A recent survey by Mercer, a benefits consultant, found that 44% of large employers covered them for obesity, an increase from 41% in 2023
Semaglutide helps lower blood sugar levels by stimulating insulin secretion when glucose levels are high and inhibiting glucagon release to prevent excessive glucose production by the liver
Heres what analysts predict